Loading company…
Unicohealth is a Guangzhou platform developing diagnostic reagents and recombinant protein drugs.
Established in 2016 and based in Guangzhou, China, Unicohealth operates a diagnostic reagent development platform. Its reagents cover clinical rapid diagnostics, immunodiagnostics, hematology, microbiology, molecular biology and clinical biochemistry. Its recombinant protein drugs are aimed at infertility, cardiovascular and cerebrovascular diseases, critical illness and cancer. The company has more than 10 domestic and foreign invention patents and has worked with Sun Yat-sen University and other research institutions. It is at the seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in